Compounding BPC-157: A regulatory loophole In a statement, Health Canada said "BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols." In addition, the regulator says BPC-157 is not approved for use in any NHPs in any form, including oral and injectable, but it can still be compounded for topical use or oral administration as an NHP
Nutrients, 12(2), 573
Learn more about Niacinamide Sodium Hyaluronate is the salt form of hyaluronic acid
BPC-157's effects on neurotransmitter systems theoretically could interact with psychiatric medications
It is important to distinguish orally administered supplements, such as collagen peptides, from injectable biologics, as oral formulations generally have a different safety profile and do not introduce risks related to sterility or injection-related complications